IMVT - Immunovant  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMVT is currently covered by 14 analysts with an average price target of $28.41. This is a potential upside of $13.52 (90.8%) from yesterday's end of day stock price of $14.89.

Immunovant 's activity chart (see below) currently has 95 price targets and 108 ratings on display. The stock rating distribution of IMVT is 97.78% BUY and 2.22% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 58.52% with an average time for these price targets to be met of 179.53 days.

Highest price target for IMVT is $53, Lowest price target is $20, average price target is $42.73.

Most recent stock forecast was given by JASON GERBERRY from BAML on 12-Aug-2025. First documented stock forecast 07-Jan-2020.

Currently out of the existing stock ratings of IMVT, 44 are a BUY (97.78%), 1 are a HOLD (2.22%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$30

$14.76 (96.85%)

$33

13 days ago
(12-Aug-2025)

1/4 (25%)

$14.79 (97.24%)

126

Buy

$37

$21.76 (142.78%)

$46

13 days ago
(12-Aug-2025)

0/3 (0%)

$21.79 (143.26%)

Buy

5 months 5 days ago
(20-Mar-2025)

3/7 (42.86%)

$24.48 (125.41%)

119

Buy

$51

$35.76 (234.65%)

$51

5 months 6 days ago
(19-Mar-2025)

11/20 (55%)

$32.12 (170.13%)

268

Hold

$20

$4.76 (31.23%)

$32

5 months 22 days ago
(03-Mar-2025)

6/6 (100%)

$-0.6 (-2.91%)

95

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMVT (Immunovant ) average time for price targets to be met?

On average it took 179.53 days on average for the stock forecasts to be realized with a an average price target met ratio 58.52

Which analyst has the current highest performing score on IMVT (Immunovant ) with a proven track record?

GBOLA AMUSA

Which analyst has the most public recommendations on IMVT (Immunovant )?

Gbola Amusa works at CHARDAN CAPITAL and has 0 price targets and 7 ratings on IMVT

Which analyst is the currently most bullish on IMVT (Immunovant )?

Yasmeen Rahimi with highest potential upside - $41.76

Which analyst is the currently most reserved on IMVT (Immunovant )?

Tiago Fauth with lowest potential downside - -$8.24

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?